Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
Synthesis and biological evaluation of pyrrolidine derivatives as novel and potent sodium channel blockers for the treatment of ischemic strokeMaki Seki, Osamu Tsuruta, Ryo Tatsumi, et al.Physical Review. E|August 1, 2025
Chaotic magnetization dynamics in magnetic Duffing oscillatorRyo Tatsumi, Takahiro Chiba, Takashi Komine, et al.Nuclear Medicine and Biology|April 25, 2006
Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agentMikako Ogawa, Ryo Tatsumi, Masakazu Fujio, et al.Journal of Drug Targeting|May 9, 2014
Comparative assessments of crucial factors for a functional ligand-targeted nanocarrierMd Nazir Hossen, Kazuaki Kajimoto, Ryo Tatsumi, et al.Bioorganic & Medicinal Chemistry Letters|June 19, 2004
(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptorRyo Tatsumi, Kohji Seio, Masakazu Fujio, et al.Journal of Medicinal Chemistry|April 2, 2005
Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligandRyo Tatsumi, Masakazu Fujio, Hiroyuki Satoh, et al.Journal of Medicinal Chemistry|July 11, 2006
(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing propertiesRyo Tatsumi, Masakazu Fujio, Shin-ichi Takanashi, et al.Pageof 1